Common lophatherum
Lophatherum gracile
Lophatherum gracile, a plant traditionally used in few documented practices, has been studied for its potential health benefits. Scientific evidence suggests that extracts from L. gracile may have antitumor activity by inducing apoptosis and altering cell cycle distribution in tumor cells. Additionally, it has shown promise in improving glucose and lipid metabolism in mice with type 2 diabetes, with key bioactive components including isoorientin, orientin, and isovitexin. While the plant's distribution patterns are expected to shift under future climate scenarios due to human activities, there is currently no strong scientific evidence supporting its use beyond these preliminary findings. Safety concerns for Lophatherum gracile appear minimal; no major issues have been recorded in existing literature. There are also no reported drug interactions associated with this plant. However, further research is necessary to confirm and expand upon the observed benefits and to better understand any potential effects or applications in traditional medicine practices.
- Best evidence
- D
- Cautions
- —
Informational only. Traditional use does not mean proven effectiveness. Evidence and safety vary — check the cited sources.
What the science says
- LGP from Lophatherum gracile showed preliminary antitumor activity in vivo by inducing apoptosis and altering cell cycle distribution in tumor cells.
- Canopy litter removal increased PPFD and transmittance, leading to higher species richness of understory vegetation, particularly heliophilic species.
- The study found that Lophatherum gracile Brongn extract improved glucose and lipid metabolism in T2DM mice, with key components isoorientin, orientin, and isovitexin involved.
- The study using Maxent model found that Lophatherum gracile's distribution in China is likely to shift westward and decrease under future climate scenarios, with human activities exacerbating habitat fragmentation.
Frequently asked questions
What is Common lophatherum?
Common lophatherum (Lophatherum gracile) is a plant documented in FolkKB's traditional-medicine reference, drawn from sourced literature and cross-checked against the evidence.
What does the scientific evidence say about Common lophatherum?
4 sourced findings are recorded for Common lophatherum; the strongest carries evidence grade D. For example: LGP from Lophatherum gracile showed preliminary antitumor activity in vivo by inducing apoptosis and altering cell cycle distribution in tumor cells.
How strong is the evidence for Common lophatherum?
The strongest finding for Common lophatherum carries evidence grade D — preliminary or traditional. Grades run A (strongest) to D (preliminary or traditional).
Is Common lophatherum safe? What are the side effects?
No major safety issues are recorded for Common lophatherum in our sources, but the data may be incomplete. Consult a qualified professional before use.
Does Common lophatherum interact with medications?
No drug interactions are recorded for Common lophatherum in our sources. This does not rule them out — check with a pharmacist.
Is Common lophatherum a proven treatment?
No. FolkKB is informational only. Traditional use and early findings are not proof of efficacy or safety — consult a qualified professional and never self-treat.
Sources
- T2 Assessing the impacts of climate change and human activities on distribution of Lophatherum gracile in China using the maxent model. literature abstract metadata
- T2 Bioactive Component Screening and Mechanistic Study of the Anti-Diabetic Activity of Lophatherum gracile Brongn Extract. literature abstract metadata
- T2 Effects of Canopy Litter Removal on Canopy Structure, Understory Light and Vegetation Dynamics in Cunninghamia lanceolata Plantations of Varying Densities. literature abstract metadata
- T2 A Water-Soluble Polysaccharide from Lophatherum gracile Brongn.: Structure Characterization and Antitumor Activity In Vivo. literature abstract metadata